pubmed-article:7851350 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C0013819 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C0022180 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C0033487 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C0002915 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C1883073 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
pubmed-article:7851350 | lifeskim:mentions | umls-concept:C0205154 | lld:lifeskim |
pubmed-article:7851350 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:7851350 | pubmed:dateCreated | 1995-3-16 | lld:pubmed |
pubmed-article:7851350 | pubmed:abstractText | Propofol and isoflurane were compared for haemodynamic stability and recovery time as main anaesthetic agents for maintenance in a total of 43 ASA I and II patients in uncomplicated operations lasting at least 30 min. The premedication (oral diazepam), induction (thiopentone-fentanyl-suxamethonium) and maintenance protocol (N2O-O2 2:1 litre min-1, fentanyl and vecuronium in incremental doses) were identical for all patients. In one group of 20 patients, propofol was used in continuous intravenous (i.v.) infusion (starting dose 3 mg kg-1 h-1), while in the second group of 23 patients, isoflurane was administered in a starting concentration of 1%. To improve the equipotency of the two agents in all cases the dose of the main anaesthetic was titrated to keep the EEG 90% spectral edge frequency (SEF-recorded by processed EEG monitor) between 8 and 12 Hz. Mean blood pressure (BP) and heart rate (HR) deviations of +/- 20% from the baseline were recorded. The incidence of mean blood pressure deviations/case in the propofol group was less than half of those occurring in the isoflurane group (0.45 vs. 0.96 P = 0.04). The mean duration of blood pressure deviation from baseline value was 5.5 min in the propofol group vs. 16.8 min in the isoflurane group (P = 0.01). The recovery intervals were significantly shorter in the propofol group (P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS) | lld:pubmed |
pubmed-article:7851350 | pubmed:language | eng | lld:pubmed |
pubmed-article:7851350 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7851350 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7851350 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7851350 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7851350 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7851350 | pubmed:month | Nov | lld:pubmed |
pubmed-article:7851350 | pubmed:issn | 0265-0215 | lld:pubmed |
pubmed-article:7851350 | pubmed:author | pubmed-author:PearlmanAA | lld:pubmed |
pubmed-article:7851350 | pubmed:author | pubmed-author:SchiltJJ | lld:pubmed |
pubmed-article:7851350 | pubmed:author | pubmed-author:GurmanG MGM | lld:pubmed |
pubmed-article:7851350 | pubmed:author | pubmed-author:PoratAA | lld:pubmed |
pubmed-article:7851350 | pubmed:author | pubmed-author:FajerSS | lld:pubmed |
pubmed-article:7851350 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7851350 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:7851350 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7851350 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7851350 | pubmed:pagination | 443-8 | lld:pubmed |
pubmed-article:7851350 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:meshHeading | pubmed-meshheading:7851350-... | lld:pubmed |
pubmed-article:7851350 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7851350 | pubmed:articleTitle | Use of EEG spectral edge as index of equipotency in a comparison of propofol and isoflurane for maintenance of general anaesthesia. | lld:pubmed |
pubmed-article:7851350 | pubmed:affiliation | Division of Anesthesiology, Ben-Gurion University of the Negev, Faculty of Health Sciences, Soroka Medical Center, Beer-Sheva, Israel. | lld:pubmed |
pubmed-article:7851350 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7851350 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7851350 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:7851350 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:7851350 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |